Concentrated exposure and response prevention for children with OCD
A Single Group Evaluation of Concentrated Exposure and Response Prevention for Children With Obsessive-compulsive Disorder
This study is testing a new week-long treatment for children aged 6-12 with OCD to see if it helps reduce their symptoms and improve their daily lives.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 6 Years to 12 Years |
| Sex | All |
| Sponsor | Uppsala University Hospital Academic / other |
| Locations | 1 site (Uppsala, Region Uppsala) |
| Trial ID | NCT06621381 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the preliminary outcomes of a concentrated exposure and response prevention approach for children aged 6-12 years with obsessive-compulsive disorder (OCD). Conducted at Uppsala University Hospital, the study involves trained therapists delivering treatment in an outpatient setting. Participants will receive psychoeducation in a group format followed by individual exposure and response prevention sessions concentrated over one week. The study aims to assess treatment effects on OCD symptoms, functional impact, family accommodation, and clinician ratings of severity and improvement.
Who should consider this trial
Good fit: Ideal candidates are children aged 6-12 years diagnosed with obsessive-compulsive disorder whose guardians consent to the treatment.
Not a fit: Patients or guardians who cannot communicate in Swedish will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce OCD symptoms in children and improve their overall functioning.
How similar studies have performed: Other studies have shown success with exposure and response prevention techniques in treating OCD, indicating that this approach is supported by existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The patient fulfills the diagnostic criteria of obsessive-compulsive disorder * The patient and the legal guardians have said yes to receiving the concentrated exposure with response prevention - treatment Exclusion Criteria: * The patient/legal guardians are unable to communicate in Swedish
Where this trial is running
Uppsala, Region Uppsala
- Uppsala University Hospital — Uppsala, Region Uppsala, Sweden (Recruiting)
Study contacts
- Principal investigator: Vendela Zetterqvist, Ph D, Associate Professor — Uppsala University Hospital
- Study coordinator: Vendela Zetterqvist, Ph D, Associate professor
- Email: vendela.zetterqvist@uu.se
- Phone: +46 (0)768107060
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.